Drug intelligence / Profile preview

jieyu qutan huazhuo

Development stage: Unknown
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

Jieyu Qutan Huazhuo is a Traditional Chinese Medicine (TCM) herbal prescription developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of metabolic disorders, including hypertriglyceridemia and dyslipidemia. The formula is designed based on TCM principles to 'relieve stagnation, remove phlegm, and resolve turbidity,' addressing the underlying patterns associated with lipid metabolism dysfunction. Clinical research has focused on its efficacy in improving lipid profiles and its sociological etiology in the context of dyslipidemia.

Other names: Jieyu Qutan Huazhuo Prescription解郁祛痰化浊方Jieyu Qutan Huazhuo decoction

Beyond the preview

Go deeper on jieyu qutan huazhuo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on jieyu qutan huazhuo.

Explore the full profile